No Data
Bernstein Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $150
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Rhythm Pharmaceuticals (RYTM)
Does Abbott Laboratories (NYSE:ABT) Have A Healthy Balance Sheet?
Abbott Laboratories To Go Ex-Dividend On January 15th, 2026 With 0.63 USD Dividend Per Share
December 12th (Eastern Time) - $Abbott Laboratories(ABT.US)$ is trading ex-dividend on January 15th, 2026.Shareholders of record on January 15th, 2026 will receive 0.63 USD dividend per share on
Abbott Laboratories Expands Board With New Appointment
Unusual Options Activity: V, ADI and Others Attract Market Bets, V V/OI Ratio Reaches 202.8
EST Dec 12th Afternoon Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options